Diagnosis and treatment of chronic graft-versus-host disease

Seminars in Hematology

Volumn 43, Issue 1, 2006, Pages 70-80

  Gilman, Andrew L ^a   Serody, Jonathan ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CLOFAZIMINE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN; PREDNISONE; RAPAMYCIN; RITUXIMAB; THALIDOMIDE;

AUTOIMMUNE DISEASE; BIOPSY; CATARACT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DRUG INHIBITION; DRUG MEGADOSE; DRUG PULSE THERAPY; ENZYME REPLACEMENT; EYE INJURY; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HEART DISEASE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INCIDENCE; INFECTION; KIDNEY INJURY; LACRIMAL GLAND; LEUKEMIA; LIVER; LIVER INJURY; LOTION; LUNG INJURY; MORBIDITY; MORTALITY; MOUTH DISEASE; MOUTH LESION; MUSCULOSKELETAL DISEASE; MYCOSIS; NERVOUS SYSTEM INJURY; NEUROPATHY; NEUTROPENIA; NONHUMAN; NUTRITION; ORGAN; OSTEOLYSIS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PUVA; RASH; REGULATORY T LYMPHOCYTE; RELAPSE; REVIEW; SCORING SYSTEM; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; STEM CELL; SYMPTOM; VAGINA DISEASE; VIRUS INFECTION; VULVA DISEASE; WEIGHT GAIN;

EID: 30344451431     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.09.008     Document Type: Article

References (73)

1. S.J. Lee, G. Vogelsang, M.E. Flowers Chronic graft-versus-host disease Biol Blood Marrow Transplant 9 2003 215 233
2. M.A. Higman, G.B. Vogelsang Chronic graft versus host disease Br J Haematol 125 2004 435 454
3. V. Ratanatharathorn, L. Ayash, H.M. Lazarus, J. Fu, J.P. Uberti Chronic graft-versus-host disease clinical manifestation and therapy Bone Marrow Transplant 28 2001 121 129
4. G.B. Vogelsang How I treat chronic graft-versus-host disease Blood 97 2001 1196 1201
5. B.L. Stewart, B. Storer, J. Storek, H.J. Deeg, R. Storb, J.A. Hansen Duration of immunosuppressive treatment for chronic graft-versus-host disease Blood 104 2004 3501 3506
6. P. Nghiem The "drug vs graft-vs-host disease" conundrum gets tougher, but there is an answer The challenge to dermatologists Arch Dermatol 137 2001 75 76
7. E. Holler Cytokines, viruses, and graft-versus-host disease Curr Opin Hematol 9 2002 479 484
8. D.A. Jacobsohn, T. Schechter, R. Seshadri, K. Thormann, R. Duerst, M. Kletzel Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children Transplantation 77 2004 1096 1100
9. K.M. Sullivan, M. Mori, J. Sanders, M. Siadak, R.P. Witherspoon, C. Anasetti Late complications of allogeneic and autologous marrow transplantation Bone Marrow Transplant 10 suppl 1 1992 127 134
10. S.J. Lee, J.P. Klein, A.J. Barrett, O. Ringden, J.H. Antin, J.Y. Cahn Severity of chronic graft-versus-host disease association with treatment-related mortality and relapse Blood 100 2002 406 414
11. H.M. Shulman, G.E. Sale, K.G. Lerner, E.A. Barker, P.L. Weiden, K. Sullivan Chronic cutaneous graft-versus-host disease in man Am J Pathol 91 1978 545 570
12. M.K. Jack, G.M. Jack, G.E. Sale, H.M. Shulman, K.M. Sullivan Ocular manifestations of graft-v-host disease Arch Ophthalmol 101 1983 1080 1084
13. M.M. Schubert, K.M. Sullivan, T.H. Morton, K.T. Izutsu, D.E. Peterson, N. Flournoy Oral manifestations of chronic graft-v-host disease Arch Intern Med 144 1984 1591 1595
14. S.I. Strasser, H.M. Shulman, M.E. Flowers, R. Reddy, D.A. Margolis, M. Prumbaum Chronic graft-versus-host disease of the liver Presentation as an acute hepatitis Hepatology 32 2000 1265 1271
15. G.B. McDonald, K.M. Sullivan, M.D. Schuffler, H.M. Shulman, E.D. Thomas Esophageal abnormalities in chronic graft-versus-host disease in humans Gastroenterology 80 1981 914 921
16. G. Akpek, W. Chinratanalab, L.A. Lee, M. Torbenson, J.P. Hallick, V. Anders Gastrointestinal involvement in chronic graft-versus-host disease A clinicopathologic study Biol Blood Marrow Transplant 9 2003 46 51
17. G. Akpek, J.L. Valladares, L. Lee, J. Margolis, G.B. Vogelsang Pancreatic insufficiency in patients with chronic graft-versus-host disease Bone Marrow Transplant 27 2001 163 166
18. K.R. Schultz, G.J. Green, D. Wensley, M.A. Sargent, J.F. Magee, J.J. Spinelli Obstructive lung disease in children after allogeneic bone marrow transplantation Blood 84 1994 3212 3220
19. A.Z. Dudek, H. Mahaseth, T.E. DeFor, D.J. Weisdorf Bronchiolitis obliterans in chronic graft-versus-host disease Analysis of risk factors and treatment outcomes Biol Blood Marrow Transplant 9 2003 657 666
20. A.P. Schwarer, J.M. Hughes, B. Trotman-Dickenson, T. Krausz, J.M. Goldman A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation Transplantation 54 1992 1002 1008
21. P. Parker, N.J. Chao, J. Ben-Ezra, N. Slatkin, H. Openshaw, J.C. Niland, C.A. Linker Polymyositis as a manifestation of chronic graft-versus-host disease Medicine (Baltimore) 75 1996 279 285
22. G.B. Bolger, K.M. Sullivan, A.M. Spence, F.R. Appelbaum, R. Johnston, J.E. Sanders Myasthenia gravis after allogeneic bone marrow transplantation Relationship to chronic graft-versus-host disease Neurology 36 1986 1087 1091
23. A. Seber, S.P. Khan, J.H. Kersey Unexplained effusions Association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease Bone Marrow Transplant 17 1996 207 211
24. L.B. Spiryda, M.R. Laufer, R.J. Soiffer, J.A. Antin Graft-versus-host disease of the vulva and/or vagina Diagnosis and treatment Biol Blood Marrow Transplant 9 2003 760 765
25. C. Rackley, K.R. Schultz, F.D. Goldman, K.W. Chan, A. Serrano, J.E. Hulse Cardiac manifestations of graft-versus-host disease Biol Blood Marrow Transplant 11 2005 773 780
26. J.A. Barbara, A.C. Thomas, P.S. Smith, D. Gillis, J.O. Ho, A.J. Woodroffe Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient Clin Nephrol 37 1992 115 118
27. E. Rouah, R. Gruber, W. Shearer, D. Armstrong, E.P. Hawkins Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol 89 1988 543 546
28. A. Greenspan, H.J. Deeg, M. Cottler-Fox, M. Sirdofski, T.R. Spitzer, J. Kattah Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease Bone Marrow Transplant 5 1990 349 352
29. T.A. O'Brien, T. Eastlund, C. Peters, J.P. Neglia, T. Defor, N.K. Ramsay Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients High incidence and significant mortality in unrelated donor transplants for non-malignant diseases Br J Haematol 127 2004 67 75
30. K. Atkinson, V. Farewell, R. Storb, M.S. Tsoi, K.M. Sullivan, R.P. Witherspoon Analysis of late infections after human bone marrow transplantation Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease Blood 60 1982 714 720
31. S. Quaranta, H. Shulman, A. Ahmed, Y. Shoenfeld, J. Peter, G.B. McDonald Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation Clin Immunol 91 1999 106 116
32. S. Kulkarni, R. Powles, J. Treleaven, U. Riley, S. Singhal, C. Horton Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants Blood 95 2000 3683 3686
33. J.L. Ferrara, H.J. Deeg Graft-versus-host disease N Engl J Med 324 1991 667 674
34. S. Romagnani, P. Parronchi, M.M. D'Elios, P. Romagnani, F. Annunziato, M.P. Piccinni An update on human Th1 and Th2 cells Int Arch Allergy Immunol 113 1997 153 156
35. A. Hess, C. Thoburn, W. Chen, L. Horwitz Autoreactive T-cell subsets in acute and chronic syngeneic graft-versus-host disease Transplant Proc 33 2001 1754 1756
36. D. De Wit, M. Van Mechelen, C. Zanin, J.M. Doutrelepont, T. Velu, C. Gerard Preferential activation of Th2 cells in chronic graft-versus-host reaction J Immunol 150 1993 361 366
37. L.L. McCormick, Y. Zhang, E. Tootell, A.C. Gilliam Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease A model for human scleroderma J Immunol 163 1999 5693 5699
38. B.E. Anderson, J.M. McNiff, D. Jain, B.R. Blazar, W.D. Shlomchik, M.J. Shlomchik Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease Requirements depend on target organ Blood 105 2005 2227 2234
39. M.R. Canninga-van Dijk, H.M. van der Straaten, R. Fijnheer, C.J. Sanders, J.G. van den Tweel, L.F. Verdonck Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Blood 104 2004 2603 2606
40. M.S. Tsoi, R. Storb, S. Dobbs, E. Santos, E.D. Thomas Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients Implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease Transplant Proc 13 1981 237 240
41. high regulatory T cells Blood 103 2004 2410 2416
42. K.M. Sullivan, H.M. Shulman, R. Storb, P.L. Weiden, R.P. Witherspoon, G.B. McDonald Chronic graft-versus-host disease in 52 patients Adverse natural course and successful treatment with combination immunosuppression Blood 57 1981 267 276
43. H.M. Shulman, K.M. Sullivan, P.L. Weiden, G.B. McDonald, G.E. Striker, G.E. Sale Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 69 1980 204 217
44. G. Akpek, M.L. Zahurak, S. Piantadosi, J. Margolis, J. Doherty, R. Davidson Development of a prognostic model for grading chronic graft-versus-host disease Blood 97 2001 1219 1226
45. G. Akpek, S.J. Lee, M.E. Flowers, S.Z. Pavletic, M. Arora, S. Lee Performance of a new clinical grading system for chronic graft-versus-host disease A multicenter study Blood 102 2003 802 809
46. K.M. Sullivan, R.P. Witherspoon, R. Storb, P. Weiden, N. Flournoy, S. Dahlberg Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 72 1988 546 554
47. S. Koc, W. Leisenring, M.E. Flowers, C. Anasetti, H.J. Deeg, R.A. Nash, J.E. Sanders Therapy for chronic graft-versus-host disease A randomized trial comparing cyclosporine plus prednisone versus prednisone alone Blood 100 2002 48 51
48. K.M. Sullivan, R.P. Witherspoon, R. Storb, H.J. Deeg, S. Dahlberg, J.E. Sanders Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease Blood 72 1988 555 561
49. M.E. Flowers, S. Lee, G. Vogelsang An update on how to treat chronic GVHD Blood 102 2003 2312 (letter)
50. P.M. Parker, N. Chao, A. Nademanee, M.R. O'Donnell, G.M. Schmidt, D.S. Snyder Thalidomide as salvage therapy for chronic graft-versus-host disease Blood 86 1995 3604 3609
51. S. Koc, W. Leisenring, M.E. Flowers, C. Anasetti, H.J. Deeg, R.A. Nash Thalidomide for treatment of patients with chronic graft-versus-host disease Blood 96 2000 3995 3996
52. A. Busca, E.M. Saroglia, E. Lanino, L. Manfredini, C. Uderzo, B. Nicolini Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation Bone Marrow Transplant 25 2000 1067 1071
53. M. Baudard, A. Vincent, P. Moreau, M.F. Kergueris, J.L. Harousseau, N. Milpied Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications A series of 21 BM or PBSC transplant patients Bone Marrow Transplant 30 2002 287 295
54. A.L. Gilman, K.W. Chan, A. Mogul, C. Morris, F.D. Goldman, M. Boyer Hydroxychloroquine for the treatment of chronic graft-versus-host disease Biol Blood Marrow Transplant 6 2000 327 334
55. L.J. Johnston, J. Brown, J.A. Shizuru, K.E. Stockerl-Goldstein, M.J. Stuart, K.G. Blume Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease Biol Blood Marrow Transplant 11 2005 47 55
56. K. Raj, S. Narayanan, B. Augustson, A. Ho, P. Mehta, N. Duncan Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation Bone Marrow Transplant 35 2005 299 301
57. C. Cutler, D. Miklos, S.J. Lee, S.B.N.T. Woo, D. Bienfang, L. Klickstein Rituximab therapy for steroid-refractory chronic GVHD Safety and efficacy analysis Blood 104 2004 619a
58. D.A. Jacobsohn, B. Browning, K. Thormann, M. Higman, M.L. Phelps, A.R. Chen Pentostatin Efficacy in refractory chronic GVHD in children Blood 104 2004 619a
59. G. Akpek, S.M. Lee, V. Anders, G.B. Vogelsang A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease Biol Blood Marrow Transplant 7 2001 495 502
60. D. Gaziev, G. Lucarelli, P. Polchi, E. Angelucci, M. Galimberti, C. Giardini A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease Bone Marrow Transplant 27 2001 45 51
61. F.M. Foss, G.M. Divenuti, K. Chin, K. Sprague, H. Grodman, A. Klein Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease Analysis of response and survival incorporating prognostic factors Bone Marrow Transplant 35 2005 1187 1193
62. E.D. Seaton, R.M. Szydlo, E. Kanfer, J.F. Apperley, R. Russell-Jones Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response Blood 102 2003 1217 1223
63. G.B. Vogelsang, D. Wolff, V. Altomonte, E. Farmer, W.L. Morison, R. Corio Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA) Bone Marrow Transplant 17 1996 1061 1067
64. M. Arora, J.E. Wagner, S.M. Davies, B.R. Blazar, T. Defor, H. Enright Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease Biol Blood Marrow Transplant 7 2001 265 273
65. F. Carnevale-Schianca, P. Martin, K. Sullivan, M. Flowers, T. Gooley, C. Anasetti Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease Biol Blood Marrow Transplant 6 2000 613 620
66. B. Mookerjee, V. Altomonte, G. Vogelsang Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus Bone Marrow Transplant 24 1999 517 520
67. G.B. Vogelsang, E.R. Farmer, A.D. Hess, V. Altamonte, W.E. Beschorner, D.A. Jabs Thalidomide for the treatment of chronic graft-versus-host disease N Engl J Med 326 1992 1055 1058
68. P.V. Browne, D.J. Weisdorf, T. DeFor, W.J. Miller, S.M. Davies, A. Filipovich Response to thalidomide therapy in refractory chronic graft-versus-host disease Bone Marrow Transplant 26 2000 865 869
69. A. Rovelli, C. Arrigo, F. Nesi, A. Balduzzi, B. Nicolini, A. Locasciulli The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children Bone Marrow Transplant 21 1998 577 581
70. S.J. Lee, S.A. Wegner, C.J. McGarigle, B.E. Bierer, J.H. Antin Treatment of chronic graft-versus-host disease with clofazimine Blood 89 1997 2298 2302
71. K.Y. Chiang, S. Abhyankar, K. Bridges, K. Godder, J.P. Henslee-Downey Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease Transplantation 73 2002 665 667
72. N. Apisarnthanarax, M. Donato, M. Korbling, D. Couriel, J. Gajewski, S. Giralt Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation feasibility and results Bone Marrow Transplant 31 2003 459 465
73. L. Salvaneschi, C. Perotti, M. Zecca, S. Bernuzzi, G. Viarengo, G. Giorgiani Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood Transfusion 41 2001 1299 1305